Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Solana CompanyNASDAQ: HSDT
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables outflow shrinks to $0
Q1 FY2026 accounts receivables was $0, compared with $133K a year earlier. Trailing-twelve-month accounts receivables was -$133K.
Context
- Accounts receivables amounted to 0.0% of revenue in FY2025, down 1.0 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$33.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- +100.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | +100.0% |
| FY2024 | 2024-12-31 | (5K) | +98.3% |
| FY2023 | 2023-12-31 | (291K) | -182.5% |
| FY2022 | 2022-12-31 | (103K) | -10400.0% |
| FY2021 | 2021-12-31 | 1K | — |
Accounts Receivables vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 accounts receivables of $133K is the 8th largest of the 11 companies compared; the peer median is $208.5K.
- Its year-over-year change of -337.5% is the 9th highest of 11, against a peer median of +97.8%.
- Accounts receivables amounts to 1.4% of revenue for HSDT, versus a peer median of 5.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.95M | -5.6% | -34.3% | 3.4% | |
| LTM Mar 2026 | $9M | +948.6% | +27.2% | 6.2% | |
| LTM Mar 2026 | $8.65M | +7764.5% | — | 7.4% | |
| LTM Mar 2026 | $3.56M | -683.9% | -25.1% | 5.0% | |
| LTM Mar 2026 | $3.49M | -927.9% | -50.3% | 18.5% | |
| LTM Mar 2026 | $2.34M | +94.0% | +9.5% | 5.3% | |
| LTM Mar 2026 | $440K | -119.2% | — | 71.2% | |
| LTM Mar 2026 | $133K | -337.5% | — | 1.4% | |
| LTM Dec 2025 | $113.84K | +135.5% | +13.1% | 0.9% | |
| LTM Mar 2026 | $108K | +104.2% | — | 0.1% | |
| LTM Mar 2026 | $23K | +101.7% | +101.4% | 0.1% | |
| Peer median (excluding HSDT) | $208.5K | +97.8% | +9.5% | 5.1% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Depreciation & Amortization | 374K | 306K | 162K | 60K | 680K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 1.63M | 2.52M | 9.25M |
| Change in Working Capital | 127K | (1.31M) | (311K) | (8K) | 230K |
| Accounts Receivables | 1K | (103K) | (291K) | (5K) | 0 |
| Inventory | (87K) | (111K) | 137K | (607K) | (85K) |
| Accounts Payables | 369K | (418K) | (103K) | 344K | 1.02M |
| Other Working Capital | (156K) | (674K) | (54K) | 260K | (702K) |
| Other Non-Cash Items | 4.24M | 762K | (3.05M) | (1.87M) | 14.22M |
| Operating Cash Flow | (13.39M) | (14.31M) | (10.42M) | (11.04M) | (16.51M) |
| Capital Expenditures | (54K) | (17K) | (29K) | (5K) | (44.78M) |
| Acquisitions (Net) | 0 | 6K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (426.53M) |
| Investing Cash Flow | (56K) | (11K) | (29K) | (5K) | (426.53M) |
| Debt Repayment | 0 | 0 | 0 | 0 | (680K) |
| Common Stock Issued | 21.13M | 17.87M | 1.08M | 6.95M | 467.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 3.99M | (17.11M) |
| Financing Cash Flow | 21.13M | 17.87M | 1.08M | 6.95M | 449.24M |
| Effect of Forex Changes | (8K) | (4K) | 1K | (2K) | 1K |
| Net Change in Cash | 7.67M | 3.54M | (9.37M) | (4.09M) | 6.19M |
| Free Cash Flow | (13.44M) | (14.33M) | (10.45M) | (11.05M) | (61.29M) |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.